Annual revenue:
$203.07M+$39.16M(+23.89%)Summary
- As of today (September 16, 2025), XERS annual revenue is $203.07 million, with the most recent change of +$39.16 million (+23.89%) on December 31, 2024.
- During the last 3 years, XERS annual revenue has risen by +$153.48 million (+309.50%).
- XERS annual revenue is now at all-time high.
Performance
XERS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$71.54M+$11.42M(+19.00%)Summary
- As of today (September 16, 2025), XERS quarterly revenue is $71.54 million, with the most recent change of +$11.42 million (+19.00%) on June 30, 2025.
- Over the past year, XERS quarterly revenue has increased by +$23.47 million (+48.84%).
- XERS quarterly revenue is now at all-time high.
Performance
XERS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$246.03M+$23.47M(+10.55%)Summary
- As of today (September 16, 2025), XERS TTM revenue is $246.03 million, with the most recent change of +$23.47 million (+10.55%) on June 30, 2025.
- Over the past year, XERS TTM revenue has increased by +$64.61 million (+35.62%).
- XERS TTM revenue is now at all-time high.
Performance
XERS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
XERS Revenue Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +23.9% | +48.8% | +35.6% |
3 y3 years | +309.5% | +182.7% | +208.0% |
5 y5 years | +7360.3% | +3429.3% | +4005.9% |
XERS Revenue Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +309.5% | at high | +182.7% | at high | +208.0% |
5 y | 5-year | at high | +7360.3% | at high | +3429.3% | at high | +4005.9% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
XERS Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $71.54M(+19.0%) | $246.03M(+10.5%) |
Mar 2025 | - | $60.12M(+0.0%) | $222.55M(+9.6%) |
Dec 2024 | $203.07M(+23.9%) | $60.10M(+10.7%) | $203.07M(+8.4%) |
Sep 2024 | - | $54.27M(+12.9%) | $187.36M(+3.3%) |
Jun 2024 | - | $48.06M(+18.3%) | $181.41M(+5.9%) |
Mar 2024 | - | $40.64M(-8.5%) | $171.36M(+4.5%) |
Dec 2023 | $163.91M(+48.7%) | $44.39M(-8.1%) | $163.91M(+7.4%) |
Sep 2023 | - | $48.32M(+27.1%) | $152.67M(+13.9%) |
Jun 2023 | - | $38.01M(+14.5%) | $134.07M(+10.5%) |
Mar 2023 | - | $33.20M(+0.2%) | $121.37M(+10.1%) |
Dec 2022 | $110.25M(+122.3%) | $33.14M(+11.5%) | $110.25M(+11.9%) |
Sep 2022 | - | $29.73M(+17.5%) | $98.53M(+23.4%) |
Jun 2022 | - | $25.31M(+14.6%) | $79.87M(+25.8%) |
Mar 2022 | - | $22.07M(+3.0%) | $63.47M(+28.0%) |
Dec 2021 | $49.59M | $21.43M(+93.8%) | $49.59M(+40.4%) |
Sep 2021 | - | $11.06M(+24.2%) | $35.33M(+4.8%) |
Jun 2021 | - | $8.91M(+8.7%) | $33.72M(+25.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $8.20M(+14.3%) | $26.84M(+31.4%) |
Dec 2020 | $20.43M(+650.7%) | $7.17M(-24.1%) | $20.43M(+35.1%) |
Sep 2020 | - | $9.45M(+366.1%) | $15.13M(+152.5%) |
Jun 2020 | - | $2.03M(+13.4%) | $5.99M(+39.8%) |
Mar 2020 | - | $1.79M(-4.1%) | $4.29M(+56.1%) |
Dec 2019 | $2.72M(+12.3%) | $1.86M(+495.5%) | $2.75M(+63.2%) |
Sep 2019 | - | $313.00K(-2.2%) | $1.68M(-13.8%) |
Jun 2019 | - | $320.00K(+29.0%) | $1.95M(-20.4%) |
Mar 2019 | - | $248.00K(-69.0%) | $2.45M(-0.6%) |
Dec 2018 | $2.42M(+55.7%) | $801.00K(+37.6%) | $2.46M(+48.1%) |
Sep 2018 | - | $582.00K(-28.9%) | $1.66M(+32.9%) |
Jun 2018 | - | $819.00K(+211.4%) | $1.25M(+189.1%) |
Mar 2018 | - | $263.00K(+54.7%) | $433.00K(-17.4%) |
Dec 2017 | $1.56M(+44.7%) | - | - |
Sep 2017 | - | $170.00K(-52.0%) | $524.00K(+48.0%) |
Mar 2017 | - | $354.00K | $354.00K |
Dec 2016 | $1.07M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual revenue?
- What is the all time high annual revenue for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual revenue year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly revenue?
- What is the all time high quarterly revenue for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly revenue year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM revenue?
- What is the all time high TTM revenue for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM revenue year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual revenue?
The current annual revenue of XERS is $203.07M
What is the all time high annual revenue for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual revenue is $203.07M
What is Xeris Biopharma Holdings, Inc. annual revenue year-on-year change?
Over the past year, XERS annual revenue has changed by +$39.16M (+23.89%)
What is Xeris Biopharma Holdings, Inc. quarterly revenue?
The current quarterly revenue of XERS is $71.54M
What is the all time high quarterly revenue for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly revenue is $71.54M
What is Xeris Biopharma Holdings, Inc. quarterly revenue year-on-year change?
Over the past year, XERS quarterly revenue has changed by +$23.47M (+48.84%)
What is Xeris Biopharma Holdings, Inc. TTM revenue?
The current TTM revenue of XERS is $246.03M
What is the all time high TTM revenue for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM revenue is $246.03M
What is Xeris Biopharma Holdings, Inc. TTM revenue year-on-year change?
Over the past year, XERS TTM revenue has changed by +$64.61M (+35.62%)